ArticleAnti-cancer agents in medicinal chemistry2026
Deciphering the Molecular Interactions of Tuberculosis and Colorectal Cancer: A Network and RNA-Seq Data Analysis Approach.
Article in Anti-cancer agents in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionA recent study revealed a correlation between TB and cancer, with individuals with a history of TB or current symptoms having a greater likelihood of developing colorectal cancer. This study aimed to explore transcriptomics data to identify new potential common therapeutic targets for CRC and tuberculosis.
methodsThe GSE11199 dataset associated with TB and the GSE33113 dataset associated with CRC were retrieved from the Gene Expression Omnibus. The study identified commonly upregulated genes via R language, built a protein‒protein interaction network, and visualized it via Cytoscape, Cytohubba, and MCODE, revealing the role of miRNAs and TFs in regulating hub genes.
resultsA total of 40 genes were found to be commonly upregulated, six of which were identified as hub genes, i.e., CXCL5, MMP3, MMP1, CXCL8, CXCL11, and SPP1. In addition, 58 miRNAs and 28 TFs were found to be associated with the hub genes. DISCUSSION: Our findings revealed that key genes associated with the tumor immune microenvironment such as CXCL5, an inflammatory chemokine; CXCL8, a neutrophil-attracting chemokine; CXCL11, which is chemotactic for activated T-cells; and SPP1, which promotes the recruitment of immune cells to the tumor microenvironment and is significantly linked with various miRNAs and transcription factors, could regulate the functions of these hub genes and contribute to the progression and pathology of CRC and TB.
conclusionThe identified genes hold strong potential to apprise the development of targeted therapeutic strategies and advance clinical applications for patients affected by both conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.